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Background: Dairy proteins, in particular the whey fraction, exert insulinogenic properties and facilitate glycemic
regulation through a mechanism involving elevation of certain plasma amino acids, and stimulation of incretins.
Human milk is rich in whey protein and has not been investigated in this respect.
Method: Nine healthy volunteers were served test meals consisting of human milk, bovine milk, reconstituted
bovine whey- or casein protein in random order. All test meals contributed with 25g intrinsic or added lactose, and
a white wheat bread (WWB) meal was used as reference, providing 25g starch. Post-prandial levels in plasma of
glucose, insulin, incretins and amino acids were investigated at time intervals for up to 2 h.
Results: All test meals elicited lower postprandial blood glucose responses, expressed as iAUC 0–120 min
compared with the WWB (P < 0.05). The insulin response was increased following all test meals, although only
significantly higher after whey. Plasma amino acids were correlated to insulin and incretin secretion (iAUC 0–60
min) (P ≤ 0.05). The lowered glycemia with the test meals (iAUC 0–90 min) was inversely correlated to GLP-1
(iAUC 0–30 min) (P ≤ 0.05).
Conclusion: This study shows that the glycemic response was significantly lower following all milk/milk protein
based test meals, in comparison with WWB. The effect appears to originate from the protein fraction and early
phase plasma amino acids and incretins were involved in the insulin secretion. Despite its lower protein content,
the human milk was a potent GLP-1 secretagogue and showed insulinogenic properties similar to that seen with
reconstituted bovine whey-protein, possibly due to the comparatively high proportion of whey in human milk.
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The prevalence of type 2 diabetes (T2D) is increasing
around the world, with sedentary lifestyles and inad-
equate dietary habits as the major causing factors. Epi-
demiological evidence suggests, that a diet characterized
by a low glycemic index (GI), protects against the devel-
opment of T2D [1]. The GI is used to establish post-
meal glycemic responses to carbohydrate rich meals.
Most often the GI correlates with Insulinemic Index (II),
measured similarly from postprandial insulinemic
responses. However, milk displays a discrepancy,* Correspondence: ulrika.gunnerud@appliednutrition.lth.se
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reproduction in any medium, provided the orshowing a low GI but yet a high II [2]. Observational
studies have indicated that a diet rich in dairy products
may protect against development of the metabolic syn-
drome and T2D [3,4]. Additionally, bovine whey protein
stimulates insulin secretion and facilitates post-meal gly-
cemic regulation in both healthy individuals and in
patients with T2D [5-8]. This may imply that co-
ingestion of milk, in particular the whey fraction, with
meals may lower glycemic excursions and thereby re-
duce the glycemic impact of the diet.
In a previous study, we have shown that whey protein
resulted in a higher insulin response than cheese (casein)
or milk (whey and casein), respectively [6]. The major
insulin releasing properties of milk could thus be
ascribed to the whey fraction, and the mechanismtral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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appearing in postprandial blood after whey ingestion [6].
When administrated with carbohydrates, dietary amino
acids stimulate the insulin release from the pancreatic β-
cell [9]. Especially leucine (leu) is a known to be strong
insulin secretagogue [10]. Consequently, the lowering of
glycemia seen when adding whey to a carbohydrate con-
taining meal can to a large extent be mimicked by sup-
plementation of the meal with specific amino acids [11].
In addition, whey proteins appear to stimulate the incre-
tin hormones glucose-dependent insulinotropic polypep-
tide (GIP) and glucagon-like peptide 1 (GLP-1) [12].
Both GLP-1 as well as GIP has been identified as strong
insulinotropic agents [13]. Furthermore, it has recently
been reported that dietary branched chain amino acids
(BCAA) facilitates GLP-1 release from intestinal-cells
[14]. Thus, plasma amino acids per se can possibly cause
an incretin secretion, and partly explain the reduction of
glycemia seen when adding whey to a carbohydrate con-
taining meal.
The protein concentration in human milk is consider-
ably lower than in bovine milk (8.5 g/L vs. 34.5 g/L)
[15]. Also the composition of the protein fractions is
substantially different, with human milk containing a lar-
ger fraction of whey protein. Consequently, the ratio
whey:casein differs between the two milk types, being
20:80 for bovine milk [16] and 50:50 – 80:20 to human
milk, with somewhat different ratios depending on the
lactating phase [17]. Based on above, it can be hypothe-
sized that human milk, despite its low protein content,
exerts insulinogenic properties due to its high whey pro-
tein content. To our knowledge, no data are available
regarding the postprandial glycemic, insulinemic and
incretin effects of human milk.
The aim of the present study was to investigate the
glycemic and insulinemic effects of human and bovine
milk in comparison with white wheat bread (WWB). In
addition, casein and whey protein fractions from bovine
milk were included. For this purpose, human milk, bo-
vine milk, bovine casein and whey proteins, respectively,
were standardized with respect to lactose content and
provided as breakfast drinks to healthy adults. The studyTable 1 Nutrient composition and serving sizes of the test me
WWB1 Whey2
Starch (g) 25 -
Lactose (g) - 25
Protein (g) 3.7 16.2
Fat (g) 2.5 7.4
Serving quantity (g) 250 490
Σ Carbohydrates (g) 25 25
1 Solid food.
2 Liquid foods.was performed in a glycemic index measuring setting,
and a carbohydrate equivalent amount of white wheat
bread (WWB) was therefore used as reference meal. In
addition to blood glucose and insulin, plasma levels of
amino acids and the incretins GIP and GLP-1 were mea-
sured in the postprandial phase.
Methods
Test meals
Four test drinks were included in the study; human
and bovine milk and reconstituted bovine whey and ca-
sein drinks. The nutritional compositions of the meals
are shown in Table 1. Human milk, whey and casein
concentrates were obtained from Arla Foods (Stock-
holm, Sweden). Bovine milk with 1.5% fat (w/v) was
obtained from a local market. The human milk was
skimmed to reduce fat content (1.5% w/v), followed by
pasteurization. According to the manufacture the whey
and casein proteins were obtained by ultrafiltration and
membrane filtration of skimmed milk. Lactose was
then added to the protein fractions and the mixtures
were dissolved in water. Each of the meals contributed
with 25 g available carbohydrates, thus the protein con-
tent differed significantly between the bovine milk and
the human milk meals (16.8 g and 3.5 g respectively).
The reconstituted whey and casein meals were set to
match the bovine milk with respect to lactose-, protein
and fat contents. The serving of whey contained 16.2 g
of protein and the casein meal contained 16.8 g pro-
tein. All the test drinks were set to match the bovine
milk in fat content (1.5% w/v). Human milk, whey and
casein drinks were kept frozen (−18°C) until use. White
wheat bread (WWB) was used as a reference meal. The
WWB was prepared in a home baking machine accord-
ing to Liljeberg and Björck [18].
Test subjects and study design
Nine healthy, non-smoking, volunteers, (6M: 3F), aged
22–30 years, with body mass index 25.8 ± 3.4 kg/ m2
(mean ± SD) and without drug treatment participated in
the study. All subjects had normal fasting blood glucose
levels (4.4 ± 0.05 mmol/l). The meals were served inals
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at least 2 days apart. When arriving at the laboratory in
the morning (8 am), a peripheral catheter was inserted
into the antecubital vein and a fasting blood sample was
drawn. At all sampling time points, samples were taken
in one tube for serum and one for plasma (EDTA), re-
spectively. The subjects were requested to consume the
test and reference meals steadily over a 12 min period.
All subjects were conscious of the possibility to with-
draw from the study at any time they desired. The study
was approved by the Ethics Committee of the Faculty of
Medicine at Lund University.Chemical analysis
Lactose content of the test meals was analyzed as galact-
ose and glucose following enzymatic hydrolysis with β-
galactosidase as described by Nilsson et al. [6].The
peptide-bound amino acids of the different food proteins
were analyzed accordingly Stenberg et al. [19] starting
with a hydrolysis step. The samples were dissolved in 6
M hydrochloric acid, containing 0.1% phenol and kept at
110°C for 20 h. As a result of the hydrolysis treatment,
tryptophan, cysteine and methionine were lost and
therefore data for these amino acids are lacking in the
results. Furthermore, due to the hydrolysis step, glutam-
ine and asparagine were converted to glutamic acid and
aspartic acid, respectively. The amino acids were ana-
lyzed using ion exchange chromatography (Biotronik
LC 5001, München, Germany). Standard lithium citrate
buffers of pH 2.85, 2.89, 3.20, 4.02 and 3.49 were used to
separate the amino acids. The post-column derivatiza-
tion was performed with ninhydrin [20]. The crude pro-
tein content in all the meals was analyzed by using the
Kjeldahl procedure (Kjeltec Auto 1030 Analyser; Tecator
Höganäs, Sweden). The starch in the WWB was deter-
mined according to the method of Holm et al. [21].Blood analysis
Venous blood samples were taken at fasting (0) and, at 7.5,
15, 30, 45, 60, 75, 90, 105 and 120 min after the meal were
initiated, for analysis of blood glucose, serum insulin and
GIP and GLP-1 analysis. Additionally, plasma was collected
at 0, 7.5, 15, 30, 45 and 60 min for amino acids analysis.
The plasma tubes were allowed to rest for 30 min before
being centrifuged at 3000 rpm during 6 min. 800 μl plasma
was separated for free amino acids analysis and the
remaining plasma was frozen at −20°C before analysis of
GIP and GLP-1. Serum tubes were centrifuged for 15 min
at 4000 rpm and serum was separated and frozen at −20°C
for insulin analysis. Whole blood glucose concentrations
were determined with a glucose oxidase-peroxidase re-
agent. The serum insulin determination was performed on
an integrated immunoassay analyzer, CODA™ OpenMicroplate System (Bio-Rad Laboratories, Hercules, USA)
using an enzyme immunoassay kit (Mercodia Insulin Elisa,
Mercodia AB, Uppsala, Sweden). Plasma GIP and GLP-1
concentrations were measured after extraction of plasma
with 70% ethanol (by vol, final concentration). For the GIP
radioimmunoassay [22], we used the C-terminal directed
antiserum R 65, that cross-reacts fully with human GIP but
not with so called GIP 8000, whose chemical nature and re-
lation to GIP secretion is uncertain. Human GIP and 125I
human GIP (70 MBq/nmol) were used for standards and
tracers. The concentration of plasma GLP-1 was measured
[23] against standards of synthetic GLP-1 7–36 amide by
using antiserum code no. 89390, which is specific for the
amidated carboxyl terminus of GLP-1 and, therefore, does
not react with GLP-1 containing peptides from the pan-
creas. For both assays sensitivity was <1 pmol/L, intraassay
CV <6% at 20 pmol/L, and recovery of standard, added to
plasma before extraction, ≈100% when corrected for losses
inherent in the plasma extraction procedure. Free amino
acids were purified by mixing 200 μl 10% sulphosalic acid
with 800 μl plasma to precipitate high molecular proteins,
according to Biotronik (München, Germany). The amino
acid solutions were frozen at −20°C until analyzed by an
amino acid analyzer (Biotronik LC 5001, München, Ger-
many) using ion exchange chromatography as described
above.Calculations and statistical methods
The results are expressed as mean ± SEM. The incre-
mental areas under the curves (iAUC) for glucose, insu-
lin, GIP, GLP-1 and plasma amino acids were calculated
for each test subject and meal, using a trapezoid model
(GraphPad Prism™, version 4.03). All areas below the
baseline were excluded from the calculations and each
subject was their own reference. Statistical comparisons
for iAUC-values were performed in MINITAB® Statis-
tical Software (release 14.13 for windows). Significances
were evaluated with the general linear model (ANOVA),
followed by Tukey´s multiple comparisons test. Statis-
tical significances were considered for values of P < 0.05.
Differences between the products at different time
points were analyzed by using a mixed model (PROC
MIXED in SAS release 9.1; SAS Institute Inc, Cary, NC)
with repeated measures and an autoregressive covari-
ance structure. When significant interactions between
treatment and time were found, Tukey’s multiple com-
parison test were performed for each time point (MINI-
TAB, release 14.13; Minitab Inc). Correlations between
dependent measures were conducted using Spearman's
partial correlation coefficients controlling for subjects
and corresponding baseline values (two-tailed test),
(SPSS software, version 19; SPSS Inc., Chicago, IL,
USA). Due to missing values the bovine milk had to be
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tions, and the amino acid isoleucine (ile) had to be
excluded from the calculations on free amino acids in
plasma. In addition, there were only eight test subjects
on the WWB and whey, and seven test subjects on the
casein and the human milk respectively included in the
GIP and GLP-1 calculations, due to missing values.
Results
Postprandial blood glucose and insulin responses
The iAUCs for plasma glucose and serum insulin are
shown in Table 2. All test meals elicited lower postpran-
dial blood glucose responses, expressed as iAUC 0–120
min, compared with the reference (WWB) (p < 0.05). A
significant treatment effect (p = 0.0002) and a significant
time × treatment interaction (p = 0.0265) was found for
blood glucose concentrations (Figure 1). The insulin
iAUC following human milk, bovine milk and casein
was similar to that seen with WWB. In contrast, the
whey meal exhibited higher insulin iAUC 0–120 min,
than the WWB (p < 0.05). Additionally, the whey meal
resulted in an elevated insulin response (iAUC 0–120
min) also when compared with data for casein and
human milk. No time × treatment interaction was found
for insulin responses (Figure 1).
Amino acid content in the test and reference meals
The amino acid concentrations of the different meals are
presented in Table 3. Bovine milk, casein and whey have
similar patterns, with higher concentrations of the
BCAA; ile, leu, and valine (val) compared to human milk
and WWB. The whey meal stands out by higher leu con-
tent, and bovine milk and casein, respectively, have
slightly higher amounts of val. In accordance to its lower
protein content, the human milk display consistently
lower content of all analyzed amino acids compared to
the whey, casein and bovine milk. In comparison to the
WWB, the human milk has higher concentrations of val,
leu and lys, whereas the WWB have high proline, glycine
and tyrosine (tyr) levels.Table 2 Postprandial incremental areas under the curve (iAUC
GLP-1 and GIP
Glucose1 Insulin1
mmol · min %4 nmol · min %4
WWB 96.8 ± 13.6a 0 10.1 ± 1.8a 0
Human milk 48.0 ± 7.6b −50 9.0 ± 1.6a −10
Whey 54.1 ± 11.7b −44 16.0 ± 2.6b +58
Casein 35.1 ± 8.4b −64 10.4 ± 1.8a +3
Bovine milk 40.6 ± 10.9b −58 11.7 ± 2.6ab +16
Values are means ± SEM. Values within the same column not sharing same letters a
1n = 9 healthy subjects.
2n = 8 healthy subjects (WWB, whey) and n = 7 (casein, human milk).
4 Change in postprandial response as a percentage of the WWB reference meal.Postprandial plasma amino acids
The 0–60 min iAUC for plasma amino acids are dis-
played in Table 4. The postprandial responses for val,
leu, lys, serine (ser), alanine and arginine (arg) were sig-
nificantly higher following whey, casein and bovine milk
compared to the WWB. Furthermore, casein and whey
resulted in a significantly higher iAUC for arg and ser
compared to the human milk. The tyr response was sig-
nificantly higher after the whey protein and the bovine
milk, respectively, compared with the WWB and the
human milk. The whey and casein meals also elicited
significantly higher plasma iAUC for threonine than all
the other meals. There were no differences between the
human milk and the WWB in any of the analyzed amino
acids in postprandial plasma.
Postprandial GLP-1 and GIP responses
The iAUCs 0–120 min for GLP-1 and GIP are shown in
Table 2. The whey meal resulted in a significantly higher
iAUC 0–120 min for both GIP as well as GLP-1, in com-
parison to all the other meals. Also in the case of the
iAUCs 0–45, 0–60 and 0–90 min, respectively the whey
meal elicited higher increment for both GIP and GLP-1
compared with WWB (p ≤ 0.05). In addition, the human
milk elicited a significantly higher early postprandial
GLP-1 response, expressed as iAUCs 0–30 and 0–45
min, compared to the WWB (p ≤ 0.05) (early iAUC not
displayed). Incretin responses following the casein meal
showed no differences compared to the WWB. Signifi-
cant differences between treatments over the entire time
course (p ≤ 0.001) and significant time × treatment inter-
actions (p ≤ 0.001) were found for both GLP-1 and GIP
responses (Figure 2).
Correlations between parameters
Correlations between plasma amino acids, serum insulin
and plasma incretins are displayed in Table 5. Positive
correlations were observed between the plasma amino
acids leu, lys, val and thr iAUC 0–60 min and the corre-
sponding iAUC for serum insulin, and plasma incretin0–120 min) for plasma glucose, serum insulin, plasma
GLP-12 GIP2
pmol · min %4 pmol · min %4
276.6 ± 118.6a 0 1115.2 ± 271.5a 0
427.2 ± 131.9a +154 699.6 ± 151.1a −37
980.2 ± 167.8b +354 2717.3 ± 665.3b +244
444.9 ± 118.8a +180 1260.1 ± 259.2a +113
- -
re significantly different (P < 0.05).
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Figure 1 Incremental changes in plasma glucose and serum insulin. Mean incremental changes (Δ) in plasma glucose (A) and serum insulin
(B) in response to equal amounts of carbohydrate. In (C) the GI and II (iAUC) are displayed. For plasma glucose a significant treatment effect
(p < 0.0002) and time × treatment interaction (p < 0.0265) were found at a given time. Values with different lowercase letters are
significantly different, p ≤ 0.05 (Tukey’s test). n = 9 healthy subject.
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val and thr) iAUC 0–45 min correlated inversely to glu-
cose response at iAUC 0-60min (data not showed). In
addition, early phase GLP-1 response, expressed as
iAUC 0–30 min, correlated positively to the early phase
insulin response (iAUC 0–30 min; r = 0.688, p < 0.001).
Moreover, did the early phase GIP and GLP-1, expressed
as iAUCs 0–15 min, correlate negatively with blood glu-
cose responses iAUC 0–90 min (r = −0.419, p = 0.040; r
= −0.374, p = 0.012, respectively).Table 3 Content of amino acids in the different meals
Meal
Amino acid WWB Whey Casein Bovine milk Human milk
mg/serving
Ala 144 760 449 500 125
Arg 80 387 525 525 129
Asp 55 1539 969 1097 273
Glu 149 2592 3341 3529 678
Gly 509 314 296 321 117
His 87 284 413 423 83
Ile 163 921 872 770 136
Leu 134 2117 1698 1668 368
Lys 191 1490 1214 1306 243
Phe 96 529 745 765 133
Pro 1344 760 1698 1734 337
Ser 98 573 765 796 136
Thr 144 715 638 689 152
Tyr 293 564 847 699 133
Val 111 760 974 1000 197Discussion
To the best of our knowledge, this is the first study
where human milk is evaluated with respect to glycemic
and insulinemic effects. The study was performed in
healthy adults with a GI setting, thus post prandial gly-
cemic and hormonal responses to the human and bovine
milk were compared to an equicarbohydrate amount of
WWB. In the present study, we found that human milk
displayed insulinogenic properties and resulted in a post-
prandial glycemic response (GI 57) that was in the same
range as that to bovine milk (GI 43) or the whey and ca-
sein fractions, respectively (GI 61 and 44). The human
milk showed the lowest insulin response (iAUC 0–120
min) in comparison to all the other meals, thus indicat-
ing that human milk display superior insulin economy.
Worth emphasizing is that the protein content of the
human milk meal was markedly lower than that of bo-
vine milk, whey and casein meals. According to our ana-
lysis, the human milk meal contained 3.5g protein as
calculated from nitrogen analysis using 6.38 as conver-
sion factor. However, it has been has reported that the
true protein content of human milk is overestimated
from nitrogen analysis due to its high non protein nitro-
gen (NPN) content (20-25% of total nitrogen) [16,17].
Consequently, the protein amount in the human milk,
used in this study, may have been overestimated. Al-
though the whey:casein ratio of the human and bovine
milk in this study was not analyzed, it has been reported
to range from 50:50 – 80:20 in human milk depending
on the lactation period [17], compared to approximately
20:80 in commercial bovine milk [16]. Our results thus
indicate that human milk may be more insulinogenic
per unit protein compared to bovine milk, and the
Table 4 Postprandial areas under the curve (iAUC 0–60 min) for the different plasma amino acids
Meal
Amino acid WWB Whey Casein Bovine milk Human milk
(mmol · min/L)
Ala 0.4 ± 0.2a 3.5 ± 0.7b 2.4 ± 0.6b 2.7 ± 0.6b 2.1 ± 0.5ab
Arg 0.2 ± 0.1a 1.0 ± 0.2b 0.9 ± 0.2b 0.9 ± 0.2b 0.5 ± 0.1ab
Glu 0.9 ± 0.5a 3.0 ± 1.1a 2.9 ± 0.5a 1.7 ± 0.5a 1.3 ± 0.5a
Gly 0.3 ± 0.1a 0.5 ± 0.1a 0.5 ± 0.2a 0.4 ± 0.2a 0.2 ± 0.1a
Hist 0.3 ± 0.1a 0.6 ± 0.1a 0.4 ± 0.1a 0.6 ± 0.2a 0.7 ± 0.4a
Leu 0.3 ± 0.1a 5.0 ± 0.5c 2.7 ± 0.5b 2.6 ± 0.5b 0.6 ± 0.2a
Lys 0.5 ± 0.3a 4.7 ± 0.6b 2.9 ± 0.6b 2.9 ± 0.6b 1.0 ± 0.3ab
Phe 0.5 ± 0.2a 0.5 ± 0.2a 0.5 ± 0.1a 0.3 ± 0.1a 0.3 ± 0.1a
Pro 2.4 ± 0.6a 2.4 ± 0.7a 2.1 ± 0.3a 3.0 ± 0.5a 1.5 ± 0.4a
Ser 0.1 ± 0.1a 1.2 ± 0.2c 0.9 ± 0.2c 0.8 ± 0.2bc 0.3 ± 0.1ab
Thr 0.2 ± 0.1a 1.7 ± 0.3b 1.3 ± 0.1b 0.8 ± 0.2a 0.6 ± 0.2a
Tyr 0.2 ± 0.1ab 1.0 ± 0.3b 0.6 ± 0.2ab 1.1 ± 0.4b 0.1 ± 0.1a
Val 0.6 ± 0.2a 3.3 ± 0.5b 3.0 ± 0.4b 2.3 ± 0.5b 0.6 ± 0.2a
Values are means ± SEM; n = 9. Values in the same column with different letters are significantly different, p < 0.05 (ANOVA followed by Tukey’s test).
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factor.
All the test products in our study yielded higher post-
prandial plasma amino acid responses compared to the
WWB reference meal, although not reaching signifi-
cance for all products. The bovine milk and the reconsti-
tuted whey and casein meals were especially prone to
affect responses of the BCAA; val and leu, and also lys
and thr. We also noticed a tendency to a rise in these
amino acids following human milk in comparison to the
WWB. We recently showed in vitro that the amino acids
ile, leu, val, lys and thr induce strong insulin secreting
properties in mouse pancreatic islets [24]. In particular,
leu is recognized as a potent insulin secretagogue
[25,26]. Moreover it has been reported that also taurine,
the second most common “amino acid” and the largest









































Figure 2 Incremental changes in plasma GIP and GLP-1. Mean increme
amounts of carbohydrate. Significant treatment effects (p < 0.001) as well a
and GIP. Values with different letters are significantly different, p < 0.05 (Tukinvolved in insulin secretion [29,30]. In the present
study, we also observed positive correlations between in-
dividual plasma amino acids and serum insulin and
plasma incretin secretion in the postprandial phase
(iAUC 0–60 min) as well as negative correlations to the
glycemic response (iAUC 0-60min). Altogether this sug-
gests that the amino acids play an important role in the
insulinogenic properties of the milk proteins and con-
tribute to lowered postprandial glycemia. Thus, it can be
suggested that amino acids appearing in plasma follow-
ing milk ingestion, may affect insulin secretion in two
ways; directly by acting on the pancreatic β-cells and in-
directly by promoting incretin release. We thus found
that human milk, bovine whey and casein respectively,
affect release of GLP-1, with the human milk resulting
in a significantly higher early response compared to the













































ntal changes (Δ) in plasma GLP-1 (A) and GIP (B) in response to equal
s time × treatment interactions (p < 0.001) were found for both GLP-1
ey’s test). n = 8 (WWB, whey) and n = 7 (human milk, casein).
Table 5 Correlations between serum insulin, GIP and
GLP-1 and plasma amino acids
Insulin GLP-1 GIP
Leu r 0.440 0.716 0.489
p 0.003 <0.001 0.007
Lys r 0.385 0.640 0.568
p 0.010 <0.001 <0.001
Thr r 0.364 0.600 0.383
p 0.015 <0.001 0.040
Val r 0.408 0.438 0.539
p 0.006 0.017 0.003
Spearman’s correlation coefficients and p-values for the relations between
increments in plasma amino acid concentrations and the corresponding serum
insulin, plasma GLP-1 and GIP increment, respectively (iAUC 0–60 min).
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ering the fact that the protein content in the human
milk meal constitutes only about 22% of that in the bo-
vine whey meal, the early GLP-1 response (iAUC 0–30
min) still reached more than 50% of that seen following
whey. Thus, it could be suggested that human milk is
prone to stimulate GLP-1. It remains to be shown if the
GLP-1 response is solely related to the proteins in the
human milk, or if other bioactive components may also
be involved.
Strong positive correlations were found between the
early GLP-1 response (iAUC 0–15 min) and postprandial
insulin release up to 30 min, as well as negative correla-
tions to blood glucose response (iAUC 0–90 min), an in-
dication that early GLP-1 release may be important for
the modulation of glycemia following both human and
bovine milk. In support of such an opinion, we recently
observed that ingestion of whey protein and free amino
acid caused an early GLP-1 secretion that reduced post-
prandial glycemia in absence of a hyper-insulinemic peak
[31]. In addition to GLP-1, the human milk also resulted
in a small elevation of early phase GIP that was signifi-
cantly higher than after the WWB reference meal at 7.5
min. GIP may be present in human milk [32], and the
response we found might result from a higher intake of
this incretin, and could possibly attenuate the postpran-
dial insulin response and facilitate glycemic regulation.
Although, little is known about to what extent ingested
GIP can maintain activity following exposure to the
acidic environment in the stomach, it could be hypothe-
sized that ingestion of intrinsic GIP could possibly con-
tribute to the incretin effect of human milk. In previous
studies of incretin responses we have preferentially seen
increase in GIP after whey ingestion [5]. Thus, it is inter-
esting that the whey meal, as well as the human milk
meal, in this study significantly increased both GLP-1
and GIP response compared to all the other meals. GLP-
1 secretion following whey ingestion has previously beenreported by Hall et al. [33]. However, in that study the
test meals contained 38E% of fat, which may have influ-
enced GLP-1 secretion. Both GLP-1 and GIP have been
identified as strong insulinotropic agents [13,34], and a
release of both these incretins after whey ingestion may
add to its insulinogenic properties. Interestingly, it was
recently reported that whey protein inhibits dipeptidyl
peptidase IV (DPP-4), an enzyme that inactivates GLP-1
[35]. Consequently, whey protein may both induce GLP-
1 secretion as well as prolong the activity of this
incretin.
In contrast to whey, the casein meal resulted in a
small incremental insulin response and had the lowest
glycemic response compared to the other test meals.
This differences in glycemic and insulinemic responses
when, comparing the casein and whey meal, is in con-
trast with observations by Hall et al. [33], who found
no differences on neither postprandial glucose nor in-
sulin responses between these proteins. However, in ac-
cordance with the present study, they observed that
whey protein, in comparison to casein, increased
plasma incretins, with higher levels of both GLP-1 and
GIP [33].
There were some limitations of the present study.
All the test meals resulted in lower blood glucose
increments compared to the WWB reference meal. It
should, however, be noted that lactose was the carbo-
hydrate source in all the test meals, whereas the
reference WWB meal contained starch. In previous
studies, we have shown that lactose has a lower gly-
cemic index (GI 68) and insulinemic index (II 50)
than the starchy WWB (GI 100 and II 100) [2]. Con-
sequently, the comparatively low glycemic properties
seen with all the present test meals could partly be
explained by the lactose per se. The number of test
subject is slightly lower (n = 9) than recommended for
standardized glycemic index determinations (n = 10)
[36]. Also, although the test subjects were used to
regular Swedish food habits where milk consumption
is frequent, differences in lactase levels might affect
glycemia to milk.
Conclusion
The present study showed that human milk as well as
bovine milk and whey and casein protein lowered the
glycemia compared to the WWB reference meal. We
also demonstrated that the human milk exerted insuli-
nogenic properties and the effect appeared to originate
from the protein fraction. Consequently, all the test
meals increased plasma amino acid levels, and the amino
acids correlated positively with both insulin secretion
and incretin responses as well as inversely to the gly-
cemic response. Interestingly, the human milk appeared
to be a particularly potent GLP-1 secretagogue. The
Gunnerud et al. Nutrition Journal 2012, 11:83 Page 8 of 9
http://www.nutritionj.com/content/11/1/83relative potency of human milk to stimulate incretins is
noteworthy and the impact of incretins for metabolism
and appetite regulation is an interesting field for further
research and should be taken into consideration when
producing baby formulas based on bovine milk.
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